Replimune (REPL) stock crashed 19% after FDA rejected RP1 melanoma drug for second time, citing trial design flaws. Trading halted twice amid volatility.
Replimune (REPL) stock plunged 19% after FDA rejected RP1 melanoma immunotherapy for the second time, citing inadequate clinical trial controls.
Michael Burry reveals new stakes in Alibaba and JD.com while increasing put options against Nvidia and Palantir, calling recent market conditions ideal.
Michael Burry buys Alibaba, JD.com, and GameStop while increasing short positions on Nvidia (NVDA) and Palantir (PLTR) through put options.
FICO stock plummeted 13% Friday as Senator Hawley launches pricing investigation and Barclays cuts target to $1,950 amid AI concerns.
PayPal (PYPL) stock rises on Canva integration news, bringing payment tools to 265M users. Second major deal in weeks as recovery attempt continues.
AMD stock surged up to 6.4% Friday as TSMC’s 35% Q1 revenue increase signaled strong AI chip demand ahead of AMD’s May 5 earnings report.
SMCI stock jumped 6% on April 10 with surging call options volume and 87% implied volatility pointing to significant upcoming moves for the AI server maker.
CrowdStrike (CRWD) stock dropped 5% on AI disruption fears before surging on Anthropic’s Project Glass Wing partnership. Full analysis of the volatility.
Nio (NIO) stock climbed 8% after posting its first quarterly profit, 98% delivery growth, and launching the ES9 SUV with in-house Shenji chips.